Tatva Chintan Pharma Chem Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.5%.

Top 17 shareholders own 89.8% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
24%	Ajaykumar Patel	5,615,345	₹6.5b	0%	no data
24%	Shekhar Somani	5,614,941	₹6.5b	0%	no data
23.8%	Chintan Shah	5,575,719	₹6.4b	0%	no data
5.9%	Nippon Life India Asset Management Limited	1,380,224	₹1.6b	-0.44%	0.05%
2.77%	SBI Funds Management Limited	648,168	₹746.2m	-0.28%	0.01%
2.3%	Goldman Sachs Asset Management, L.P.	539,117	₹620.7m	12%	no data
2.01%	ICICI Prudential Asset Management Company Limited	469,793	₹540.9m	-6.7%	0.01%
1.64%	Mirae Asset Global Investments Co., Ltd.	383,348	₹441.3m	0%	0.01%
1.23%	Abu Dhabi Investment Authority	286,650	₹330.0m	0%	0.03%
1.19%	Union Asset Management Company Pvt. Ltd.	277,916	₹320.0m	0%	0.31%
0.52%	PGIM India Asset Management Private Limited	121,050	₹139.4m	0%	0.06%
0.18%	BlackRock, Inc.	43,011	₹49.5m	13.4%	no data
0.17%	Darshana Shah	39,628	₹45.6m	0%	no data
0.027%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	6,430	₹7.4m	0%	no data
0.019%	State Street Global Advisors, Inc.	4,560	₹5.2m	-1.19%	no data
0.0036%	Shitalkumar Somani	843	₹969.5k	0%	no data
0.0021%	Samirkumar Somani	482	₹554.8k	0%	no data